Catalyst Wire Dossier Catalyst Wire Dossier

Biapenem

Biapenem · Rempex Pharmaceuticals (a subsidiary of The Medicines Company)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Biapenem, covering 2013-07-11 to 2013-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination [Phase 1]

See pricing